1 asset in Intestinal Neuroendocrine Tumor G1
Therapeutic assets addressing Intestinal Neuroendocrine Tumor G1, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Paltusotine Intestinal Neuroendocrine Tumor G1 | Crinetics Pharmaceuticals Inc. | P3 | BB (66) |